Rituximab News and Research

RSS
Rituximab is approved by the Food and Drug Administration (FDA) to be used alone or with other drugs to treat certain types of B-cell non-Hodgkin lymphoma. It is also approved to be used with methotrexate to treat rheumatoid arthritis. Rituximab is also being studied in the treatment of other types of cancer and other conditions.
Rituximab, used to treat rheumatoid arthritis (RA) is safe and effective

Rituximab, used to treat rheumatoid arthritis (RA) is safe and effective

Rituximab provides new hope for people with lupus

Rituximab provides new hope for people with lupus

Radioimmunotherapy streamlines non-Hodgkin's lymphoma treatment

Radioimmunotherapy streamlines non-Hodgkin's lymphoma treatment

FDA knocks back anticancer drug Marqibo

FDA knocks back anticancer drug Marqibo

GlaxoSmithKline acquires full marketing and development rights for BEXXAR worldwide

GlaxoSmithKline acquires full marketing and development rights for BEXXAR worldwide

Zevalin highly effective in first-line treatment of low-grade follicular lymphoma

Zevalin highly effective in first-line treatment of low-grade follicular lymphoma

Genasense shown to enhance the anti-lymphoma activity of Velcade and Rituxan

Genasense shown to enhance the anti-lymphoma activity of Velcade and Rituxan

Cancer drug effective at treating lupus

Cancer drug effective at treating lupus

Genentech announces FDA approval of Avastin manufacturing

Genentech announces FDA approval of Avastin manufacturing

Results from study of Rituxan in rheumatoid arthritis show promise

Results from study of Rituxan in rheumatoid arthritis show promise